The effects of estrone (Ogen) on spinal bone density of postmenopausal women.

The effects of cyclical treatment with estrone sulfate (0.3, 0.625, or 1.25 mg), plus calcium carbonate, on spinal trabecular bone density were compared with placebo in 120 postmenopausal women in this 2-year, multicenter, double-blind study. While the placebo and 0.3-mg treatment groups lost bone density (-3.6% and -5.1%), the 0.625- and 1.25-mg treatment groups experienced no significant change from baseline at 24 months (-0.8% and +0.7%). The 1.25-mg treatment group was significantly different from the placebo group at 12, 18, and 24 months. Although the 0.625-mg treatment group was significantly different from the placebo group only at 18 months, the data suggest that 0.625 and 1.25 mg of estrone sulfate had different effects than placebo and 0.3 mg of estrone sulfate and, given with supplemental calcium, are effective doses for the prevention of spinal bone loss.

[1]  C C Glüer,et al.  Spinal bone mineral density measured with quantitative CT: effect of region of interest, vertebral level, and technique. , 1990, Radiology.

[2]  H. Genant,et al.  Mild versus definite osteoporosis: Comparison of bone densitometry techniques using different statistical models , 1989, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[3]  H. Genant,et al.  Mild versus definite osteoporosis: Comparison of bone densitometry techniques using different statistical models , 1989 .

[4]  L. Avioli,et al.  Coherence therapy does not prevent axial bone loss in osteoporotic women: a preliminary comparative study. , 1988, The Journal of clinical endocrinology and metabolism.

[5]  C. Christiansen,et al.  Does calcium supplementation prevent postmenopausal bone loss? A double-blind, controlled clinical study. , 1987, The New England journal of medicine.

[6]  H. Genant,et al.  Postmenopausal bone loss is prevented by treatment with low-dosage estrogen with calcium. , 1987, Annals of internal medicine.

[7]  G. Eklund,et al.  The Risk of Endometrial Neoplasia and Treatment with Estrogens and Estrogen ‐ Progestogen Combinations: First results of a cohort study after one to four completed years of observation , 1986, Acta obstetricia et gynecologica Scandinavica.

[8]  M. Whitehead.  Prevention of Endometrial Abnormalities , 1986, Acta obstetricia et gynecologica Scandinavica. Supplement.

[9]  R. Lindsay,et al.  The Minimum Effective Dose of Estrogen for Prevention of Postmenopausal Bone Loss , 1984, Obstetrics and gynecology.

[10]  R. Francis,et al.  The Effect of Estrogen Dose on Postmenopausal Bone Loss , 1983 .

[11]  C. Christiansen,et al.  Dose-response evaluation of cyclic estrogen/gestagen in postmenopausal women: placebo-controlled trial of its gynecologic and metabolic actions. , 1982, American journal of obstetrics and gynecology.

[12]  C. Christiansen,et al.  Pathophysiological mechanisms of estrogen effect on bone metabolism. Dose-response relationships in early postmenopausal women. , 1982, The Journal of clinical endocrinology and metabolism.

[13]  H. Genant,et al.  Quantitative Computed Tomography of Vertebral Spongiosa: A Sensitive Method for Detecting Early Bone Loss After Oophorectomy , 1982, Annals of internal medicine.

[14]  C. Christiansen,et al.  BONE MASS IN POSTMENOPAUSAL WOMEN AFTER WITHDRAWAL OF OESTROGEN/GESTAGEN REPLACEMENT THERAPY , 1981, The Lancet.

[15]  A. Lagrelius.  TREATMENT WITH ORAL ESTRONE SULPHATE IN THE FEMALE CLIMACTERIC , 1981, Acta obstetricia et gynecologica Scandinavica.

[16]  J. Studd,et al.  Endometrial disease after treatment with oestrogens and progestogens in the climacteric. , 1980, British medical journal.

[17]  C. Christiansen,et al.  Prevention of early postmenopausal bone loss: controlled 2‐year study in 315 normal females , 1971, European journal of clinical investigation.

[18]  H. E. Meema,et al.  Preventive effect of estrogen on postmenopausal bone loss. , 1975, Archives of internal medicine.

[19]  R. Lindsay,et al.  Oestrogen Replacement Therapy for Prevention of Osteoporosis after Oophorectomy , 1973, British medical journal.